fda tirzepatide announcement The is proposing the removal of three GLP-1 drugs from the 503B bulks list of active ingredients that outsourcing facilities can use to make compounded medicines, the agency announced on Thursday FDA declares Mounjaro, Zepbound shortage

Any degradation from temperature excursions, improper pH during reconstitution, or exposure to proteolytic enzymes renders it inactive

Collect, Assess, Plan, Implement, Follow Up: Monitor and Evaluate 2

I came across this GLP-1 - on Facebook and decided to give it a try

Alembic Pharmaceuticals Limited Boehringer Ingelheim Sources Primary Research Interviews: Endocrinologists and diabetologists Pharmacy benefit manager (PBM) formulary leads Brand and medical affairs at GLP-1 / DPP-4 manufacturers Diabetes educators Databases: IQVIA MIDAS Symphony Health PHAST Evaluate Pharma Citeline (Trialtrove) Magazines: Pharmaceutical Executive FiercePharma Endocrine News Diabetes Self-Management Journals: The Lancet Diabetes & Endocrinology Diabetes Care (ADA) Diabetologia (EASD) The New England Journal of Medicine Newspapers: The Wall Street Journal Financial Times Reuters The New York Times Associations: American Diabetes Association (ADA) European Association for the Study of Diabetes (EASD) International Diabetes Federation (IDF) Endocrine Society Public Domain Sources: U.S

In this Ask Me Anything episode of The Art of Being Well , Im tackling your most pressing health questions